| DLQIX | GFACX | DLQIX / GFACX | |
| Total Expense Ratio | 0.75 | 1.35 | 56% |
| Annual Report Gross Expense Ratio | 0.88 | 1.35 | 65% |
| Fund Existence | 29 years | 25 years | - |
| Gain YTD | 3.625 | 8.336 | 43% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 139M | 361B | 0% |
| Annual Yield % from dividends | 0.52 | 0.00 | - |
| Returns for 1 year | 0.75 | 9.31 | 8% |
| Returns for 3 years | -22.94 | 39.75 | -58% |
| Returns for 5 years | -47.03 | 9.24 | -509% |
| Returns for 10 years | -3.01 | 92.48 | -3% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NMIMX | 30.52 | 0.03 | +0.09% |
| Columbia Large Cap Enhanced Core Inst | |||
| CIRCX | 82.04 | 0.04 | +0.05% |
| American Funds Capital Income Bldr 529C | |||
| PHLCX | 9.59 | N/A | N/A |
| PGIM Jennison Health Sciences C | |||
| STLYX | 43.71 | N/A | N/A |
| SEI Tax-Managed Large Cap Y (SIMT) | |||
| TMITX | 9.64 | N/A | N/A |
| Transamerica Mid Cap Growth I3 | |||